United States Biologics Outsourcing Market to hit US$ 64.57 Billion By 2033 | Leading Companies - AbbVie Inc., Boehringer Ingelheim International GmbH, Catalent, Inc, Charles River Laboratories

Market Size and Forecast:

The global biologics outsourcing market reached US$ 20.10 billion in 2023, with a rise of US$ 22.92 billion in 2024, and is expected to reach US$ 64.57 billion by 2033, growing at a CAGR of 12.1% during the forecast period 2025-2033.

The Biologics Outsourcing Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/biologics-outsourcing-market?ca

Biologics outsourcing involves delegating the development and manufacturing of complex biologic drugs-such as monoclonal antibodies, vaccines, and cell therapies-to specialized contract service providers. This approach helps pharmaceutical companies reduce costs, accelerate time-to-market, and leverage advanced technologies and regulatory expertise, driving innovation and efficiency in the biopharmaceutical industry.

Recent Key Developments of United States and Japan:

USA

September 2025: Investment surged to a record $7.2 billion in September, with 97% of the capital directed toward US biomanufacturing facilities, led by FUJIFILM Biotechnologies opening a $3.2 billion biomanufacturing facility to accelerate domestic biologics capacity.

September 18, 2025: GSK committed a $30 billion investment over five years in its US R&D and supply chain, including $1.2 billion for a new AI-powered biologics "flex factory," demonstrating a major push by large pharma toward advanced domestic outsourcing models.

Japan

September 4, 2025: ProductLife Group announced the opening of a new office in Tokyo, Japan, as part of a strategic expansion to provide global clients with local expertise to navigate Japan's complex regulatory environment for biologics and advanced therapies.

Ongoing Trend (Jul-Sept 2025): There was a continued focus on RegTech Integration by Japanese outsourcing firms, which are adopting AI-based compliance tracking systems to streamline regulatory submissions for biologics due to Japan's stringent PMDA requirements.

List of the Key Players in the Biologics Outsourcing Market:

AbbVie Inc.
Boehringer Ingelheim International GmbH
Catalent, Inc
Charles River Laboratories
WuXi Biologics
CordenPharma
Rentschler Biopharma SE
Syngene International Limited

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/biologics-outsourcing-market?ca

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Segments Covered in the Biologics Outsourcing Market:

➥ By Service Type: Process Development, Cell Development, Analytical Services, Others
➥ By Product: Antibodies, Vaccines, Cell and Gene Therapies, Recombinant Proteins, Others
➥ By Process Stage: Clinical, Commercial, Research
➥ By Source: Mammalian, Microorganisms
➥ By Outsourcing Model: CDMO, CMO, CRO
➥ By End-User: Biotech Companies, Pharmaceutical Companies, Research Organizations, Others

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=biologics-outsourcing-market?ca

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Biologics Outsourcing Market market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Biologics Outsourcing Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Biologics Outsourcing Market leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Biologics Outsourcing Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ca

People Also Ask:

◆ How big is the Biologics Outsourcing Market in 2025?
◆ What is the projected growth rate of the Biologics Outsourcing Market through 2033?
◆ Who are the key players in the Biologics Outsourcing Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.